Hepatitis C Virus Infection Among Injecting Drug Users: Has Harm Reduction Worked?
- 1 January 1999
- journal article
- editorial
- Published by Taylor & Francis in Addiction Research
- Vol. 7 (1) , 1-6
- https://doi.org/10.3109/16066359909004370
Abstract
(1999). Hepatitis C Virus Infection Among Injecting Drug Users: Has Harm Reduction Worked? Addiction Research: Vol. 7, No. 1, pp. 1-6. doi: 10.3109/16066359909004370This publication has 23 references indexed in Scilit:
- Epidemiology of hepatitis CHepatology, 1997
- Epidemiology of hepatitis C virus infection among injecting drug users in Australia.Journal of Epidemiology and Community Health, 1997
- The Australian Study of HIV and Injecting Drug Use. Part I: Prevalence for HIV, hepatitis B and hepatitis C among injecting drug users in four Australian citiesDrug and Alcohol Review, 1997
- Methadone maintenance and hepatitis C virus infection among injecting drug usersAddiction, 1997
- Effectiveness of needle-exchange programmes for prevention of HIV infectionThe Lancet, 1997
- Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviourAddiction, 1996
- Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.American Journal of Public Health, 1996
- Maintaining Low HIV Seroprevalence in Populations of Injecting Drug UsersJAMA, 1995
- Tideline and Turn: Possible Reasons for the Continuing Low HIV Prevalence among Glasgow's Injecting Drug UsersSociological Review, 1994
- The Natural History of Community-Acquired Hepatitis C in the United StatesNew England Journal of Medicine, 1992